Note: Ingredients listed on restricted chemical lists
EC/CAS
200-015-4/50-18-0
Name of the chemical
Cyclophosphamide (INN) and its salts
Concentration
60-61
General Information
Revision date
2012-09-13
Product name
SYKLOFOSFAMID, CYCLOBLASTIN, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMID, CYCLOSTIN, NEOSAR
Chemical name
Alkylating Agent
CAS No.
50-18-0
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
DANGER
Section 2
SECTION 2: Hazards identification
Appearance: White crystalline powder
Signal word
DANGER
Hazard statements
Toxic if swallowed. May cause cancer. May damage fertility or the unborn child. May cause genetic defects.
Additional information
Long Term: The use of this drug during pregnancy has resulted in birth defects. Animal studies have shown a potential to cause adverse effects on the fetus. Repeat-dose studies in animals have shown a potential to cause adverse effects on reproductive system. Known Clinical Effects: Effects on blood and blood-forming organs have also occurred.
EU Classification
EU Indication of danger: Toxic Toxic to reproduction: Category 1 Carcinogenic: Category 1 Mutagenic: Category 1 EU Hazard Symbols: EU Risk Phrases: _______________________________________________________________________________________________________ R25 - Toxic if swallowed. R45 - May cause cancer. R46 - May cause heritable genetic damage. R60 - May impair fertility. R61 - May cause harm to the unborn child. Australian Hazard Classification
Hazardous Ingredients
Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.